Dr. Pestell received an M.B.B.S. from the University of Western Australia, an F.R.A.C.P. (Endocrinology and Oncology training), an M.D. and a Ph.D. from the University of Melbourne, an F.A.C.P. (Fellow American College of Physicians), and an M.B.A. from New York University. He has been in executive leadership at USA Universities and Medical Centers since 2002.
He completed Post Doctoral studies at Harvard Medical School and Massachusetts General Hospital. He was subsequently faculty at Northwestern University Medical School, Professor at Albert Einstein College of Medicine, and Chairman of the Department of Oncology at Georgetown University and Associate Vice President at Georgetown University Medical School. He has previously Executive Vice President of Thomas Jefferson University, Philadelphia. He has served as Director of two NCI-designated Cancer Centers (Lombardi Comprehensive Cancer Center, Sidney Kimmel Cancer Center, 2002-2015), founded two biotechnology companies and is the author of multiple issued patents.
He is concurrently Distinguished Professor, Translational Medical Research, and the President of the Pennsylvania Cancer and Regenerative Medicine Research Center at the Baruch S. Blumberg Institute.
He has received a number of awards for his work in clinical activity, research and education in Medicine including elected membership to the American Association for the Advancement of Science, Elected Member, American Society for Clinical Investigation, Fellow of the Royal Society of Medicine, Doctor Honoris Causa, University of Western Australia, Doctorus Honorus Causa Medical Science from University of Melbourne, RD Wright Medallion, and the Eric Sussman Prize.
Dr Pestell’s work has more than 56,700 citations and an H-index of 129, i10 index 413 (https://scholar.google.com/citations?user=RYlsfBQAAAAJ&hl=en&oi=ao). He is top ranked by Google Scholar for his areas of research including: cell cycle (#1), prostate cancer (#1), Oncology (#6) and Breast cancer (#7)
On July 17th, 2020, the New York Board of Regents voted to approve Xavier University School of Medicine Aruba to place students in long-term clinical clerkship in New York State for 7 years. This is the longest term of approval that can be given to an International Medical School.
New York State Education Department approval allows:
• Xavier graduates to enter residency training in New York
• Xavier students to complete all 72 weeks of clinical training in New York teaching hospitals